News & Press Releases

Filter
427 found

MMV delivers testimony to US congress

05 Dec 2011
General

Marketing authorization for Eurartesim® announced at media roundtable

30 Nov 2011
R&D

New dual-acting antimalarial compounds discovered

17 Nov 2011
R&D

Partnership reaches important milestone

14 Nov 2011
Partner, R&D

Eurartesim® receives stringent regulatory approval from the EMA

10 Nov 2011
General, R&D

Patient screening underway for Pyramax® sub-study in Sotuba, Mali

09 Nov 2011
R&D

SMS for Life wins WSJ Innovation Award 2011

31 Oct 2011
Access & product management

MMV Symposium at EDCTP

20 Oct 2011
General

Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities

11 Oct 2011
General, Partner

Launch of the CAPSS Plus Pilot in Uganda

30 Sep 2011
Access & product management

Chinese scientist wins award for life-saving discovery of artemisinin

23 Sep 2011
General

Molecule moves through preclinical development in record time

02 Sep 2011
Partner, R&D

MMV ESAC member receives accolade for malaria research

22 Aug 2011
Partner, R&D

Pyramax® edges closer to patients

19 Aug 2011
Partner, R&D

The Ian Bathurst Sponsorship Programme

07 Jul 2011
Donors

MMV holds malaria session at The World Conference of Science Journalists

01 Jul 2011
General

MMV loses a dear colleague and friend

28 Jun 2011
General

Artemisinin’s key impurities identified and made available as reference standards

20 Jun 2011
R&D

MMV supports new technique to measure quality of artemisinin

06 Jun 2011
R&D

Ray Chambers takes over from Baroness Chalker as MMV's Chairman

01 Jun 2011
General

DHODH awarded MMV’s Project of the Year 2010

01 Jun 2011
General, Partner

MMV participates in Asia Pacific efforts to eliminate malaria

25 May 2011
R&D

Sanofi-aventis and MMV join forces to develop innovative malaria drugs

05 May 2011
Partner, R&D

Ray Chambers among TIME's Top 100

21 Apr 2011
General

Press briefing to mark World Malaria Day

21 Apr 2011
General

"SMS for Life" rolled-out nationwide in the United Republic of Tanzania

18 Apr 2011
Access & product management

MMV’s CEO delivers strong message at Oslo malaria conference

13 Apr 2011
General

Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria

18 Mar 2011
Partner, R&D

WHO: Low quality drugs continue to afflict Africa

25 Feb 2011
General

G-FINDER 2010: Good news with a twist in the tail for PDPs

18 Feb 2011
Donors, General

Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin

15 Feb 2011
Partner, R&D

Single-dose cure for malaria edges closer to the clinic

08 Feb 2011
Partner, R&D

MMV signs MoU with ALMA at the African Union Summit

03 Feb 2011
Access & product management, Partner

Ground-breaking trial underway to protect pregnant women from malaria

28 Jan 2011
R&D

WHO report calls for urgent action to protect malaria therapies

12 Jan 2011
General

Global plan for artemisinin resistance containment (GPARC)

11 Jan 2011
General

MMV's new CEO comes on board

05 Jan 2011
General

Letter from the CEO

22 Dec 2010
General

World Malaria Report shows scale-up of control activities is paying-off

14 Dec 2010
General

International status granted to three not-for-profit organizations in Switzerland

09 Dec 2010
General

WHO report calls for greater vigilance to allow early detection of artemisinin resistance

18 Nov 2010
General

MMV-supported artesunate for injection receives WHO prequalification

08 Nov 2010
R&D

Conclusive win of artesunate over quinine

08 Nov 2010
R&D

MMV announces new Chairman of the Board effective 2011

21 Oct 2010
General

Germany to give €20M to neglected disease research

20 Oct 2010
Donors

MMV appoints new CEO

12 Oct 2010
General

MMV ESAC member in Times Top 100 Scientists

11 Oct 2010
General

Optimizing development of combination therapies: the regulatory perspective

08 Oct 2010
R&D

Selecting the right partner drug: experts debate the issues

13 Sep 2010
R&D

MMV, Novartis and partners discover novel antimalarial drug candidate

03 Sep 2010
R&D

MMV becomes first PDP to make its IP freely available for neglected diseases research

16 Aug 2010
R&D

MMV to screen Ferrer compound library

15 Jul 2010
R&D

Malawi – determined to control malaria

14 Jul 2010
Access & product management

AstraZeneca and MMV join efforts in the fight against malaria

28 Jun 2010
R&D

Data from MMV-supported research now in the public domain

20 May 2010
Open source, R&D

Experts sought for Global Fund Technical Review Panel

14 May 2010
General

Over 5 million compounds screened

03 May 2010
R&D

MMV and Anacor join hands in hunt for new antimalarial compounds

26 Apr 2010
Partner, R&D

Ambrose Talisuna: Advocating for access

23 Apr 2010
Access & product management

MMV supports trials of a new preventive treatment option for pregnant women

23 Apr 2010
Partner, R&D

Pages